Winston et al. found that NDEs extracted from the plasma of patients with mild cognitive impairment and AD are able to seed p-tau pathology and induce AD-like neuropathology in the brains of normal mice (Winston et al., 2016). Here, MAPT is linked to Alzheimer disease.